CD276 and lung cancer: The overexpression of B7-H3 in some malignancies, such as prostate cancer [35], clear cell renal cancer, lung cancer, and ovarian cancer, is associated with few tumor-infiltrating lymphocytes, low cancer severity, and poor prognosis.